Table 4.
Summary of findings for NHT versus control in obese adults
| Outcome and follow-up | Patients (studies), N | Absolute effects (95% CI) | Certainty | What happens |
|---|---|---|---|---|
| Difference | ||||
| BMI |
170 (7 RCTs) |
0.34 (−0.16 to 0.85) |
⨁⨁⨁◯ Moderatea,b |
NHT likely results in little to no difference in BMI.NHT probably results in little to no difference in BMI. |
| Body Fat Percentage |
121 (5 RCTs) |
0.21 (−3 to 3.41) |
⨁◯◯◯ Very lowa,c,d,e |
The evidence is very uncertain about the effect of NHT on Body Fat Percentage. |
| Body Weight |
125 (5 RCTs) |
0.12 (−1.99 to 2.22) |
⨁⨁◯◯ Lowa,f |
NHT may result in little to no difference in Body Weight. |
| Fat Mass |
114 (5 RCTs) |
1.1 (0.24 to 1.95) |
⨁⨁⨁◯ Moderatea,g |
NHT likely increases Fat Mass slightly. |
| Waist Circumference |
114 (4 RCTs) |
−1.26 (−9.38 to 6.87) |
⨁⨁◯◯ Lowa,h |
The evidence suggests that NHT results in little to no difference in Waist Circumference. |
CI Confidence interval, MD Mean difference
aSome concerns across majority of studies due to inability to blind participants to hypoxic intervention
bCI approaches clinical threshold but remains non-significant; moderate sample (n=170)
cI²=71%, substantial heterogeneity, p=0.001
dMixed measurement methods (DXA, BIA, skinfolds) with different accuracy profiles
eVery wide CI (−3.00 to 3.41) crosses both clinical thresholds; small sample
fWide CI crosses null and includes both benefit and harm; small sample size (n=125)
gMixed measurement methods
hExtremely wide CI (−9.38 to 6.87) crosses null AND both clinical decision thresholds; very small sample (n=114)